Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer. - Tran TTT; Phung CD; Yeo BZJ; Prajogo RC; Jayasinghe MK; Yuan J; Tan DSW; Yeo EYM; Goh BC; Tam WL; Le MTN (EBioMedicine, 2024)